Advertising

NYSE:EBS

41.89
0.83 (1.94%) 1d
0
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »
SELL

A disaster. He feels bad for J&J that they ever signed a contract with them.

biotechnology / pharmaceutical
COMMENT
EBS is helping to produce Covid vaccines. Despite this, the stock has been hammered 25% from recent high, a victim of the current rotation favouring reopening stocks and dumping other sectors. The stock has gotten too cheap at 10x earnings; it's a growth stock.
biotechnology / pharmaceutical
BUY

Instead of buying a single vaccine-making pharma, consider this. They have an established vaccine business and are working on plasma-based treatments for Covid. They also have a big contract manufacturing business of vaccines with JNJ, AZN and Novavax. This has fallen $40 from its August peak. But last night they issued bullish future numbers for this year, and the stock jumped 4.7% today. More upside to come.

biotechnology / pharmaceutical
WATCH

They're involved with JNJ and will mass-produce their Covid vaccine. He expects JNJ will release the next effective vaccine. EBS stock has done nothing because there's no news yet.

biotechnology / pharmaceutical
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Emergent BioSolutions (EBS-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for Emergent BioSolutions is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Emergent BioSolutions (EBS-N) Frequently Asked Questions

What is Emergent BioSolutions stock symbol?

Emergent BioSolutions is a American stock, trading under the symbol EBS-N on the New York Stock Exchange (EBS). It is usually referred to as NYSE:EBS or EBS-N

Is Emergent BioSolutions a buy or a sell?

In the last year, 2 stock analysts published opinions about EBS-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Emergent BioSolutions .

Is Emergent BioSolutions a good investment or a top pick?

Emergent BioSolutions was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Emergent BioSolutions .

Why is Emergent BioSolutions stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Emergent BioSolutions worth watching?

2 stock analysts on Stockchase covered Emergent BioSolutions In the last year. It is a trending stock that is worth watching.

What is Emergent BioSolutions stock price?

On 2021-12-03, Emergent BioSolutions (EBS-N) stock closed at a price of $41.89.